Search Results

ASG Superconductors’ MgB2 superconducting technology is at the heart of the worldwide innovation presented in Dresden in the field of proton therapy and cancer treatment using real-time MRI imaging.

ASG Superconductors and Siemens Healthineers signed a partnership agreement to synergistically develop UHF MRI systems of unprecedented dependability for ground-breaking brain research.

ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology.

ASG Superconductors and its US subsidiary Paramed Medical Systems Inc. are pleased to announce the second installation with American Health Imaging – a leading operator of medical imaging centers in the USA.

SG Superconductors and its US subsidiary Paramed Medical Systems Inc. are pleased to announce American Health Imaging (AHI) - A Leading Operator of Medical Imaging Centers in the USA - as their newest launch Partner for its unique MROpen MR system.

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.

The American Society for Gastrointestinal Endoscopy is pleased to announce a collaboration with Surgical Science to develop new gastrointestinal endoscopy simulation-based training and curricula for GI fellows and advanced fellows, as well as general and advanced endoscopists.

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE: ASG) (OTCQB: ASAPF) is pleased to announce that it has completed a non-brokered private placement offering of units (“Units”) for gross proceeds of approximately CDN$1.9 million (the “Offering”).

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced today announced it has scheduled a conference call to update investors and discuss its third quarter fiscal 2023 financial results that ended September 30, 2023.

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its second quarter fiscal 2023 financial results that ended June 30, 2023.